[Form 4] USANA Health Sciences Inc Insider Trading Activity

Rhea-AI Filing Summary

CEO & Director Karl G. Glassman filed a Form 4 showing the acquisition of 272.0722 Leggett & Platt (LEG) common shares on 07/25/2025 at an average price of $8.7805 (code A). Post-transaction, Glassman directly owns 1,427,943.7582 shares and indirectly holds 28,497.442 shares through the company’s retirement plan. No derivative activity or additional transactions were reported.

Insights

Financial Analyst

TL;DR: Routine insider buy; 272 shares is de-minimis vs. 1.43 M stake—signal neutral.

The filing reflects a small acquisition, likely automatic (e.g., dividend reinvestment), by CEO Karl Glassman at $8.78. The added shares increase his direct ownership by less than 0.02%, bringing total control—including retirement plan holdings—to roughly 1.46 million shares. Given the immaterial size, the event does not meaningfully alter insider sentiment or the investment thesis for LEG. Impact on valuation or market perception is expected to be negligible.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Benedict Peter

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UT 84120

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF INFORMATION OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/25/2025		M		598	A	(1)	2,849	D
Common Stock	07/25/2025		F		176	D	$31.95	2,673	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/25/2025		M			598	(2)	(2)	Common Stock	598	$0	23,521	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on the Anniversary of July 25th, 2024.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many LEG shares did CEO Karl Glassman acquire on 07/25/2025?

He acquired 272.0722 common shares.

What is Karl Glassman’s total direct LEG share ownership after the transaction?

His direct ownership stands at 1,427,943.7582 shares.

At what price were the shares acquired according to the Form 4?

The average purchase price was $8.7805 per share.

Was the transaction classified as an acquisition or disposition?

The filing lists the transaction code A, indicating an acquisition.

Were any derivative securities involved in this Form 4 filing?

No derivative security transactions were reported.